Champions Oncology website screenshot

Champions Oncology

Champions Oncology (NASDAQ: CSBR) is a global preclinical and clinical oncology contract research organization (CRO) supporting pharmaceutical and biotech drug development from discovery through the clinic. It maintains a living bank of more than 1,400 patient-derived tumor models and primary hematological models, and offers proprietary in vivo and ex vivo platforms, next-generation sequencing (WES/RNASeq), quantitative and phospho-proteomics, flow cytometry, and other analytical assays. Its Lumin Bioinformatics platform is an integrated, no-code analytics and visualization solution built on precisely curated multi-omics oncology data assembled from over 12,000 cancer patients, exposing gene networks, molecular signatures, target discovery, and AI-driven predictive analytics to researchers. Champions was surfaced as a portfolio company of Battery Ventures and added to the API Evangelist network.

Champions Oncology is profiled on the APIs.io network. Tagged areas include Company, Oncology, Cancer Research, Bioinformatics, and Contract Research Organization.

Champions Oncology’s developer surface includes documentation, getting-started guide, engineering blog, support, and 7 more developer resources.

21.1/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyOncologyCancer ResearchBioinformaticsContract Research OrganizationDrug DevelopmentGenomicsProteomicsLife SciencesPrecision MedicineData PlatformHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 21.1/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 5.2 / 20
Commercial Clarity 6.8 / 20
Operational Transparency 0.7 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/champions-oncology: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Champions Oncology Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Get Started 2

Portal, sign-up, and the first successful call

Documentation 1

Reference material describing how the API behaves

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: champions-oncology
name: Champions Oncology
description: 'Champions Oncology (NASDAQ: CSBR) is a global preclinical and clinical oncology contract research organization
  (CRO) supporting pharmaceutical and biotech drug development from discovery through the clinic. It maintains a living bank
  of more than 1,400 patient-derived tumor models and primary hematological models, and offers proprietary in vivo and ex
  vivo platforms, next-generation sequencing (WES/RNASeq), quantitative and phospho-proteomics, flow cytometry, and other
  analytical assays. Its Lumin Bioinformatics platform is an integrated, no-code analytics and visualization solution built
  on precisely curated multi-omics oncology data assembled from over 12,000 cancer patients, exposing gene networks, molecular
  signatures, target discovery, and AI-driven predictive analytics to researchers. Champions was surfaced as a portfolio company
  of Battery Ventures and added to the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/champions-oncology/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- battery-ventures
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
image: https://www.championsoncology.com/hs-fs/hubfs/Champions_Logo_New_White.png
tags:
- Company
- Oncology
- Cancer Research
- Bioinformatics
- Contract Research Organization
- Drug Development
- Genomics
- Proteomics
- Life Sciences
- Precision Medicine
- Data Platform
- Healthcare
apis: []
common:
- type: DomainSecurity
  url: security/champions-oncology-domain-security.yml
- type: Website
  url: https://www.championsoncology.com/
- type: Documentation
  url: https://lumin.championsoncology.com/lumin/docs/
- type: GettingStarted
  url: https://lumin.championsoncology.com/lumin/docs/gettingStarted.html
- type: GitHubOrganization
  url: https://github.com/Champions-Oncology
- type: Blog
  url: https://blog.championsoncology.com/blog
- type: Support
  url: https://www.championsoncology.com/contact-us
- type: Login
  url: https://lumin.championsoncology.com/login/
- type: PrivacyPolicy
  url: https://www.championsoncology.com/privacy-policy
- type: TermsOfService
  url: https://www.championsoncology.com/2023-legal-notice
- type: LLMsTxt
  url: llms/champions-oncology-llms.txt
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence